Laboratory research reveals how statins inhibit metastasis of some cancers
the ONA take:
Scientists have known that statins sometimes appear to have anticancer activities; however, they were not clear on what the mechanism was. Clinical trials on the use of statins as an anticancer drug have yielded mixed results.
Research from the University of Pittsburgh School of Medicine may have found how this effect works. Statins appear to interfere with the cholesterol synthesis process cancer cells need to reprogram themselves from an adherent state to a mobile state, thereby preventing metastases.
Most cancer deaths are caused by metastases rather than the primary tumor, making the interruption in this process a significant step in improving patient outcomes.
Cancer cell lines that contain the protein vimentin inside the cell, but do not display the protein E-cadherin on their surface, are particularly sensitive to statins. Eventually, clinicians may be able to test biopsy samples for this biomarker to determine if statins would be effective.
Although statins may not effective on their own, adding statins to the treatment of the primary tumor may prevent metastasis, and possibly prevent those cells that break away from surviving or reactivating in other parts of the body.
The researchers stress that these results were seen in a laboratory setting, and the process may work differently in the human body.
Clinical trials on the use of statins as an anticancer drug have yielded mixed results.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|